Literature DB >> 25117687

What would you like to eat, Mr CKD Microbiota? A Mediterranean Diet, please!

Eustacchio Montemurno1, Carmela Cosola, Giuseppe Dalfino, Giuseppe Daidone, Maria De Angelis, Marco Gobbetti, Loreto Gesualdo.   

Abstract

In this review we elucidate the role of gut microbiota as the plausible missing link between food and health, focusing on chronic kidney disease (CKD). Microbiota, the microbial community harboured in the large intestine, is considered a symbiotic "supplementary organ". It contributes to digestion, mainly through two catabolic pathways: saccharolytic (fermentation) or proteolytic (putrefaction). It also interacts with host influencing immunity, metabolism, and health status. It is believed that a balanced healthy microbiota is primarily saccharolytic and diet has a deep effect on its composition. Mediterranean Diet, UNESCO "Intangible Cultural Heritage of Humanity", prevents cardiovascular and metabolic systemic diseases, thanks to the high supply of fibres and antioxidants. Mediterranean Diet also favours the prevalence of saccharolytic species, while Western Diet promotes the shift towards a proteolytic profile (dysbiosis). Emerging evidences highlight the association between a wide range of diseases and dysbiosis. In CKD a vicious circle exists, in which proteolytic-derived microbial metabolites (p-cresol and indoxyl sulphate), represent the main circulating uremic toxins: their accumulation worsens dysbiosis and promotes CKD progression. Gut microbiota shaping through non-pharmacologic nutritional treatments, based on Mediterranean Diet, represents an innovative approach in CKD, potentially restoring microbiota balance, ameliorating CKD conditions and slowing down disease progression.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2014        PMID: 25117687     DOI: 10.1159/000355785

Source DB:  PubMed          Journal:  Kidney Blood Press Res        ISSN: 1420-4096            Impact factor:   2.687


  34 in total

1.  Fecal microbiota analysis of polycystic kidney disease patients according to renal function: A pilot study.

Authors:  Rabi Yacoub; Girish N Nadkarni; Daniel I McSkimming; Lee D Chaves; Sham Abyad; Mark A Bryniarski; Amanda M Honan; Shruthi A Thomas; Madan Gowda; John C He; Jaime Uribarri
Journal:  Exp Biol Med (Maywood)       Date:  2018-12-12

2.  Bowel movement frequency, oxidative stress and disease prevention.

Authors:  Alphons J M Vermorken; Emmanuel Andrès; Yali Cui
Journal:  Mol Clin Oncol       Date:  2016-08-10

Review 3.  Microbiota issue in CKD: how promising are gut-targeted approaches?

Authors:  Carmela Cosola; Maria Teresa Rocchetti; Alice Sabatino; Enrico Fiaccadori; Biagio Raffaele Di Iorio; Loreto Gesualdo
Journal:  J Nephrol       Date:  2018-08-01       Impact factor: 3.902

Review 4.  Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease.

Authors:  Alice Sabatino; Giuseppe Regolisti; Carmela Cosola; Loreto Gesualdo; Enrico Fiaccadori
Journal:  Curr Diab Rep       Date:  2017-03       Impact factor: 4.810

Review 5.  Stop chronic kidney disease progression: Time is approaching.

Authors:  Usama Abdel Azim Sharaf El Din; Mona Mansour Salem; Dina Ossama Abdulazim
Journal:  World J Nephrol       Date:  2016-05-06

6.  Probiotics-Supplemented Low-Protein Diet for Microbiota Modulation in Patients with Advanced Chronic Kidney Disease (ProLowCKD): Results from a Placebo-Controlled Randomized Trial.

Authors:  Andreana De Mauri; Deborah Carrera; Marco Bagnati; Roberta Rolla; Matteo Vidali; Doriana Chiarinotti; Marco Pane; Angela Amoruso; Mario Del Piano
Journal:  Nutrients       Date:  2022-04-14       Impact factor: 6.706

7.  Effect of Whole-Grain Barley on the Human Fecal Microbiota and Metabolome.

Authors:  Maria De Angelis; Eustacchio Montemurno; Lucia Vannini; Carmela Cosola; Noemi Cavallo; Giorgia Gozzi; Valentina Maranzano; Raffaella Di Cagno; Marco Gobbetti; Loreto Gesualdo
Journal:  Appl Environ Microbiol       Date:  2015-09-18       Impact factor: 4.792

Review 8.  The role of chronic kidney disease-associated dysbiosis in cardiovascular disease.

Authors:  Mark A Bryniarski; Fares Hamarneh; Rabi Yacoub
Journal:  Exp Biol Med (Maywood)       Date:  2019-01-25

9.  Unconjugated p-cresol activates macrophage macropinocytosis leading to increased LDL uptake.

Authors:  Lee D Chaves; Sham Abyad; Amanda M Honan; Mark A Bryniarski; Daniel I McSkimming; Corrine M Stahura; Steven C Wells; Donna M Ruszaj; Marilyn E Morris; Richard J Quigg; Rabi Yacoub
Journal:  JCI Insight       Date:  2021-06-08

10.  In Vitro Selection of Probiotics, Prebiotics, and Antioxidants to Develop an Innovative Synbiotic (NatuREN G) and Testing Its Effect in Reducing Uremic Toxins in Fecal Batches from CKD Patients.

Authors:  Mirco Vacca; Giuseppe Celano; Marcello Salvatore Lenucci; Sergio Fontana; Flavia Maria la Forgia; Fabio Minervini; Aurelia Scarano; Angelo Santino; Giuseppe Dalfino; Loreto Gesualdo; Maria De Angelis
Journal:  Microorganisms       Date:  2021-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.